Metabolomics of Bladder Cancer 1st Edition

Metabolomics of Bladder Cancer, 1st Edition by Vishwajeet Singh and Mukul Kumar Singh offers a cutting-edge, clinically focused exploration of metabolomic approaches transforming bladder cancer research and care. This authoritative volume captures the latest methods in mass spectrometry, NMR, and bioinformatic analysis to profile urinary and tissue metabolites for diagnosis, prognosis, and therapeutic monitoring.

Beginning with clear explanations of study design, sample collection, and quality control, the book moves into practical workflows for targeted and untargeted metabolomics, statistical modeling, and pathway interpretation. Case studies and translational examples demonstrate how metabolite signatures can distinguish tumor stages, predict recurrence, and guide precision therapy—making complex science accessible to clinicians and researchers alike.

Ideal for oncologists, clinical chemists, translational researchers, and graduate students, this edition balances methodological rigor with real-world applicability. You’ll find in-depth discussions of biomarker validation, regulatory considerations, and integration with genomics and proteomics to support multi-omics strategies in bladder cancer research.

What sets this book apart is its focus on moving discoveries from bench to bedside: actionable protocols, reproducible data-analysis pipelines, and practical guidance for implementing metabolomics in hospital and laboratory settings worldwide. Whether you’re building a research program, designing clinical trials, or seeking to understand the metabolic landscape of bladder cancer, this book is an indispensable resource.

Discover the science shaping next-generation diagnostics and personalized care for bladder cancer. Order your copy of Metabolomics of Bladder Cancer, 1st Edition today and equip your team with the tools to advance research and improve patient outcomes.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.